Aesthetic medicine products. L’Oréal USA appoints new Chief Sustainability Officer for North America

Derma filler

THE WHAT? L’Oréal USA has announced the appointment of Marissa Pagnani McGowan as Chief Sustainability Officer for North America, effective November 2021. 

THE DETAILS Reporting to L’Oréal USA President & CEO Stéphane Rinderknech, who oversees L’Oréal‘s North America zone, McGowan will also join the U.S. management committee and the leadership team of L’Oréal‘s Global Chief Corporate Responsibility Officer, Alexandra Palt.

McGowan joins the French beauty company from her role as Chief Sustainability Officer at global fashion company PVH Corp. 

Fat dissolving

This role saw her undertake work on environmental sustainability, human rights, social impact, responsible business practices, transparency, and fostering diversity, inclusion, and equity throughout the supply chain.

THE WHY? McGowan was said to be chosen for the position due to her ‘passion for the power of partnerships and collective action.’

Rinderknech said, “Marissa brings to her sustainability work a passion for the power of partnerships and collective action. She has an impressive track record of building sustainable business platforms and embedding sustainability principles into every part of a business.

“We aim to drive a complete transformation of our business – to be a leader and catalyst of change in the beauty sector and beyond. I firmly believe that we must act with even more urgency to address the social and environmental needs of the planet while preparing our business to meet the opportunities of our dynamic market.”

Aesthetic medicine products are developed and regulated to meet stringent safety and efficacy standards. They are typically administered by trained healthcare professionals such as dermatologists, plastic surgeons, and specialized nurses in clinical settings. These products aim to provide effective solutions for cosmetic enhancement, skin rejuvenation, and overall aesthetic improvement, contributing to both physical appearance and self-confidence.

  Aesthetic medicine products. Yooma reports Q3 ‘significant growth’; forecasts Q4 revenue to exceed US$5 million

Key categories of aesthetic medicine products include:

  • Injectables: This category includes products such as dermal fillers, botulinum toxins (e.g., Botox), and collagen stimulators. These injectables are used to smooth wrinkles, add volume, and improve facial contours.

  • Skin Rejuvenation Treatments: Products like chemical peels, microdermabrasion systems, and laser devices are used to improve skin texture, reduce pigmentation irregularities, and enhance overall skin tone.

  • Skincare Products: These include medical-grade cleansers, moisturizers, serums, and topical treatments containing active ingredients like retinoids, antioxidants, and growth factors. They are formulated to address specific skin concerns such as acne, aging, and hyperpigmentation.

  • Hair Restoration Products: Medical treatments and products designed to promote hair growth and treat conditions such as male and female pattern baldness.

  • Body Contouring and Fat Reduction: Devices and products used for non-surgical body sculpting, such as cryolipolysis (cool sculpting) devices and injectable lipolytics.

  • Cosmeceuticals: High-performance skincare products that bridge the gap between cosmetics and pharmaceuticals, often containing potent ingredients with proven clinical benefits.

  • Wound Care and Scar Management: Products like silicone sheets, gels, and advanced wound dressings used to improve healing and reduce the appearance of scars.